5 Pharmaceutical Stocks to Buy According to Timothy Lynch’s Stonepine Capital

3. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)

Stonepine Capital’s Stake Value: $14.446 million

Percentage of Stonepine Capital’s 13F Portfolio: 7.43%

Number of Hedge Fund Holders: 15

Based on the latest 13F holdings for the second quarter of 2021, Stonepine Capital owns over 2.6 million shares in Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) worth $14.226 million. On August 9, Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) posted the earnings for Q2 2021. The company posted earnings per share of $ -$0.27, beating the market predictions by $0.02. The revenue was announced to be $21.97 million, up 12.48% year over year, which beat market predictions by $160,000.